Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Instil Bio, Inc. Director's Dealing 2025

Apr 28, 2025

33728_dirs_2025-04-28_11a47fcb-f0ef-4aa4-931f-43704167c576.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2025-04-25

Reporting Person: Laumas Sandeep (CFO and CBO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-04-25 Employee Stock Option (right to buy) $12.78 A 44851 Acquired 2035-04-24 Common Stock (44851) Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option vest on April 25, 2026, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.